Restorative cell therapy for Parkinson's disease: a quest for the perfect cell
Vanessa J Hall1, Jia-Yi Li, Patrik Brundin
1Neuronal Survival Unit, Department of Experimental Medical Science, Wallenberg Neuroscience Center, Solvegatan 17, BMC A10, Lund 22184, Sweden. Vanessa.hall@med.lu.se
Abstract:
The development of a cell therapy for the neurodegenerative disorder Parkinson's disease is a realistic ambition. It is pursued by researchers and companies alike, and spans different donor tissue types of embryonic, fetal and adult origins. In this review, we briefly outline the past and current status of research and clinical trials with cell transplantation in Parkinson's disease. We discuss studies on donor tissue derived from embryonic ventral mesencephalon and assess the current research on various forms of stem cells of both embryonic and adult origins in the quest to develop a cell-based therapy for this debilitating movement disorder.
Insights
Cell therapy for Parkinson's disease is advancing, using various cell sources like embryonic and stem cells. Research and clinical trials are ongoing to develop effective treatments for this neurodegenerative disorder.
Area of Science:
- Neuroscience
- Regenerative Medicine
- Cell Therapy
Background:
- Parkinson's disease is a debilitating neurodegenerative movement disorder.
- Cell transplantation is a promising therapeutic strategy for Parkinson's disease.
- Research spans embryonic, fetal, and adult donor tissue types.
Purpose of the Study:
- To review the current status of cell therapy research and clinical trials for Parkinson's disease.
- To discuss donor tissue sources, including embryonic ventral mesencephalon and stem cells.
- To assess the potential of cell-based therapies for Parkinson's disease.
Main Methods:
- Review of existing research and clinical trial data.
- Analysis of studies utilizing embryonic ventral mesencephalon grafts.
- Assessment of embryonic and adult stem cell research for Parkinson's disease therapy.
Main Results:
- Cell therapy development for Parkinson's disease is a realistic and active area of research.
- Various donor tissue sources are being investigated, each with potential benefits and challenges.
- Stem cells, both embryonic and adult, are a key focus for future therapies.
Conclusions:
- Cell-based therapies hold significant promise for treating Parkinson's disease.
- Continued research into donor tissue and stem cell sources is crucial for therapeutic advancement.
- The development of effective cell therapies could significantly improve outcomes for Parkinson's patients.
More Related Videos
Related Concept Videos
EPS and iPS Cells in Disease Research
iPS Cell Differentiation
Induced Pluripotent Stem Cells
Induced Pluripotent Stem Cells
Somatic cells are...
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Stem Cell Culture


